Results 211 to 220 of about 4,908,635 (315)

Sustainable procurement practice in the public sector: An international comparative study [PDF]

, 2007
Stephen Brammer, Helen Walker
openalex  

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

Factors influencing the implementation of a general practice nurse-led intervention to improve social connectedness among older people in Australia: a qualitative descriptive study. [PDF]

J Res Nurs
Thompson C, Halcomb E, Montgomery A, Peters K.   +3 more
europepmc   +1 more source

Indian Society of Periodontology Good Clinical Practice Recommendations for Peri-implant Care

Anurag Satpathy, Vishakha Grover, Ashish Kumar, Ashish Jain, Dharmarajan Gopalakrishnan, Harpreet Singh Grover, Abhay Kolte, Anil Melath, Manish Khatri, Nitin Dani, Roshani Thakur, Vaibhav Tiwari, Vikender Singh Yadav, Biju Thomas, Gurparkash Singh Chahal, Meenu Taneja Bhasin, Nymphea Pandit, Sandeep Anant Lawande, R. G. Shiva Manjunath, Surinder Sachdeva, Amit Bhardwaj, Avni Raju Pradeep, AshishSham Nichani, Baljeet Singh, Praveen Ganesh, Neeraj Deshpande, Saravanan Sampoornam Pape Reddy, Subash Chandra Raj   +27 more
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Inside Out: The Influence of Identity, Context and Time on Faculty Motivation and Engagement. [PDF]

Clin Teach
Shaffer K, Lamb SM, Chow CJ.
europepmc   +1 more source

National roll-out of social prescribing in England's primary care system: a longitudinal observational study using Clinical Practice Research Datalink data

Feifei Bu, Alexandra Burton, Naomi Launders, Amy E. Taylor, Alvin Richards‐Belle, Stephanie Tierney, David Osborn, Daisy Fancourt   +7 more
openalex   +1 more source

Cognitive Lock-In and the Power Law of Practice

, 2003
Eric J. Johnson, Steven Bellman, Gerald L. Lohse   +2 more
openalex   +2 more sources

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source